Generics 1



Medical devices



Lacosamide manufacturers

1 products found



Filters , active

Country of origin : China

Clear all

1 products found


Capsules, enteric coated 50 mg

Dossier type
Dossier status
Ready to file
Country of origin
GMP approvals
Registered in
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #25406


Lacosamide is a medication used in the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. It is used alone and in combination with other medications to control certain types of seizures in adults and children 4 years of age and older to prevent and control seizures. Lacosamide is in a class of medications called anticonvulsants or antiepileptic drugs. It works by reducing the spread of seizure activity in the brain by decreasing abnormal electrical activity in the brain. Lacosamide is the prescribed in the treatment of Temporal Lobe Epilepsy, Focal Impaired Awareness or Complex Partial Seizures, Secondarily Generalized Seizures or Bilateral Tonic-Clonic Seizure, Focal Aware or Simple Partial Seizure.
Lacosamide the generic name for the brand drug called Vimpat. Schwarz Pharma got FDA approval for clinical use in 2008. UCB Pharma acquired Schwarz Pharma in 2007, and following its approval, Lacosamide has been marketed by UCB Pharma or its partners.

Dosage and forms:

Lacosamide is available in multiple formulations including oral tablets, syrup, and intravenous (IV) infusion. When used with other seizure medicines in adults, Lacosamide usual initial recommended dose starts at 100 mg daily and in some cases, the patients may be started on 200 mg daily and increased weekly. Amongst children, the usual recommended dose for kids between 11 kg and less than 30 kg is 6 mg to 12 mg per kilogram of body weight each day. For kids who weigh between 30 kg and less than 50 kg, the usual standard dose is 4 mg to 8 mg per kilogram of body weight each day. And for kids who weigh more than 50 kg and higher, the usual initial dose is 50 mg, taken twice a day and can be increased as per the Doctor’s discretion.

The cost of Lacosamide:

As of 2020, the consumer has to pay around $823 Vimpat intravenous solution for a supply of 200 mg/20 mL, for a supply of 200 milliliters and 60 tablets of 100mg costs $1054. However, the costs of this medicine are significantly lower in the developing world. In India, the same supply for 60 tablets of 100mg sells for as low as $15.

How does it work?

Brain cells work and talk to each other through electrical discharges. These discharges must fire at a certain frequency to function normally. Sodium channels are like gates of brain cells, as in, they carry electrical activity from one cell to another. Lacosamide actions slow down these electrical discharges in some way or the other. Because its action either turns off or slows down the sodium channels in the brain. Thus the patient finds relief from the seizure and allows the brain cells to recover.

Finding Lacosamide Manufacturers and Suppliers:

The process of finding trusted Lacosamide manufacturers and Lacosamide suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities.
The robust search engine makes it convenient to search for manufacturers and suppliers of Lacosamide. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.